Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Exchange Rate Effect (2018 - 2025)

10x Genomics' Exchange Rate Effect history spans 8 years, with the latest figure at $43000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 115.99% year-over-year to $43000.0; the TTM value through Dec 2025 reached $484000.0, up 395.12%, while the annual FY2025 figure was $484000.0, 395.12% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $43000.0 at 10x Genomics, up from -$33000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $360000.0 in Q2 2025 and bottomed at -$269000.0 in Q4 2024.
  • The 5-year median for Exchange Rate Effect is $1500.0 (2021), against an average of $23850.0.
  • The largest annual shift saw Exchange Rate Effect plummeted 3300.0% in 2022 before it skyrocketed 12100.0% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$82000.0 in 2021, then surged by 406.1% to $251000.0 in 2022, then plummeted by 69.32% to $77000.0 in 2023, then crashed by 449.35% to -$269000.0 in 2024, then skyrocketed by 115.99% to $43000.0 in 2025.
  • Per Business Quant, the three most recent readings for TXG's Exchange Rate Effect are $43000.0 (Q4 2025), -$33000.0 (Q3 2025), and $360000.0 (Q2 2025).